상처 관리용 생물학적 제제 시장 규모, 점유율, 성장 분석 : 제품 유형별, 창상 유형별, 최종사용자별, 지역별 - 업계 예측(2026-2033년)

Global Wound Care Biologics Market size was valued at USD 1.88 Billion in 2024 and is poised to grow from USD 1.98 Billion in 2025 to USD 2.97 Billion by 2033, growing at a CAGR of 5.2% during the forecast period (2026-2033).

The global wound care biologics market is witnessing notable expansion, fueled by technological advancements and increasing demand for innovative healing solutions. Biologics, which encompass growth factors, cytokines, and stem cells, are proving effective for treating complex conditions like chronic wounds and diabetic ulcers. The rising incidence of chronic diseases and an aging population more prone to slow-healing wounds are significant contributors to this market's growth. Additionally, the trend towards personalized medicine and advanced therapies is prompting healthcare providers to integrate biologics for enhanced patient outcomes. However, challenges remain, including high costs that limit accessibility, stringent regulatory barriers, competition from traditional treatments, and insufficient awareness among healthcare professionals in certain areas, which could impact overall market penetration.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Wound Care Biologics market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Wound Care Biologics Market Segments Analysis

Global Wound Care Biologics Market is segmented by Product, Wound Type, End User and region. Based on Product, the market is segmented into Biological Skin Substitutes and Topical Agents. Based on Wound Type, the market is segmented into Ulcers, Surgical & Traumatic Wounds and Burns. Based on End User, the market is segmented into Hospitals, Ambulatory Surgery Centers and Burn Care Centers & Wound Clinics. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Wound Care Biologics Market

The rising prevalence of chronic wounds, including diabetic foot ulcers and pressure ulcers, plays a crucial role in propelling the growth of the wound care biologics market. These biologic products provide innovative and effective therapeutic solutions that enhance the healing process for complex wound cases. As the need for advanced wound management solutions continues to increase due to the growing patient population affected by these conditions, the demand for biologic interventions remains robust. This trend highlights the essential role that wound care biologics play in addressing the significant challenges associated with chronic wound healing.

Restraints in the Global Wound Care Biologics Market

The stringent regulatory approval process for biologic wound care products presents significant challenges that can hinder their timely market entry. This complex and often lengthy procedure not only prolongs the timeline for bringing these innovative solutions to consumers but also escalates development costs for manufacturers. As companies navigate the intricate landscape of compliance and validation, they may face financial constraints and resource allocation issues, which can affect their competitiveness and ability to introduce new products. Consequently, these regulatory hurdles serve as a notable restraint on the growth of the global wound care biologics market.

Market Trends of the Global Wound Care Biologics Market

The Global Wound Care Biologics market is experiencing a notable trend towards personalized medicine, emphasizing the customization of treatment protocols to align with individual patient needs and specific wound characteristics. This shift reflects a broader healthcare movement that prioritizes tailored therapies, enhancing the efficacy of wound care interventions. Biologics are increasingly recognized for their ability to facilitate individualized healing solutions, leveraging advanced technologies and biomaterials that adapt to diverse wound profiles. As healthcare providers seek to improve patient outcomes through targeted approaches, the demand for innovative wound care biologics that support personalized strategies is poised for significant growth.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2025
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Case Studies

Global Wound Care Biologics Market Size by Product & CAGR (2026-2033)

• Market Overview
• Biological Skin Substitutes
  • Human Donor Tissue-derived Products
  • Acellular Animal-derived Products
  • Biosynthetic Products
• Topical Agents

Global Wound Care Biologics Market Size by Wound Type & CAGR (2026-2033)

• Market Overview
• Ulcers
  • Diabetic Foot Ulcers
  • Venous Ulcers
  • Pressure Ulcers
  • Other Ulcers
• Surgical & Traumatic Wounds
• Burns

Global Wound Care Biologics Market Size by End User & CAGR (2026-2033)

• Market Overview
• Hospitals
• Ambulatory Surgery Centers
• Burn Care Centers & Wound Clinics

Global Wound Care Biologics Market Size & CAGR (2026-2033)

• North America (Product, Wound Type, End User)
  • US
  • Canada
• Europe (Product, Wound Type, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product, Wound Type, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product, Wound Type, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product, Wound Type, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Smith & Nephew (United Kingdom)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Integra LifeSciences (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Organogenesis Holdings Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• MiMedx Group, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Osiris Therapeutics, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Aroa Biosurgery (New Zealand)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Avita Medical (Australia)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Derma Sciences, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Alliqua BioMedical, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Amnio Technology, LLC (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Tissue Regenix Group plc (United Kingdom)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• CollPlant Biotechnologies Ltd. (Israel)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• RenovaCare, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• PolarityTE, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cytori Therapeutics, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Histogenics Corporation (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Vericel Corporation (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• RepliCel Life Sciences Inc. (Canada)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations